The Claim
BPC 157 at a concentration of 2 μg/ml significantly increases the number of migrating tendon fibroblasts from rat tendon explants by day 7 compared to untreated controls, accelerating ex vivo outgrowth.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When tendon tissue from rats is treated with BPC 157 at 2 μg/ml, more tendon cells migrate out of the tissue by day 7 than in untreated tissue.
See the scientific wording
BPC 157 at 2 μg/ml significantly accelerates the ex vivo outgrowth of tendon fibroblasts from rat tendon explants, increasing the number of migrating cells by day 7 compared to untreated controls, suggesting it enhances early tendon repair processes.
BPC 157 triggers a chain reaction in tendon cells that makes them move faster and survive better when injured. It turns on a molecular switch that rebuilds the cell's internal skeleton, helping the cells pull themselves forward. At the same time, it shields the cells from damage caused by harmful chemicals released during injury, so more cells stay alive and keep moving into the wound area.
What the research says
1 studyWhen scientists added BPC 157 to rat tendon pieces in a dish, more tendon cells moved out and spread around — just like the claim said. It didn’t make more cells, but it made the existing ones move faster, which helps healing start sooner.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.